PE 25.27
EY=(EPS÷SP)×100=3.92%
FCF= OCF - ICF= 51,773,000 - 2,409,000=
49,363,000
P/FCF=MC÷FCF=944,600,000 ÷ 49,363,000=
19.1
P/FCF yield=(FCF÷MC)×100=
5.22%
The OCF operating cash flow for the trailing period is 51.773 m but It's also considered as H1 FY2016
The P/FCF price to free cash flow is better than the headline PE and EY earning yield.
The stock is attractive and undervalued.
The Sp has been fluctuated wildly as there're alot of uncertainties.
The monies for modifications are received from the Pentagon rather than Austal's hip pocket so why was the Sp retreated.
I'm buying more for sure.
- Forums
- ASX - By Stock
- ASB
- Ann: ASX Spotlight Conference Series 2016 NY presentation
Ann: ASX Spotlight Conference Series 2016 NY presentation, page-2
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ASB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$3.17 |
Change
0.080(2.59%) |
Mkt cap ! $1.072B |
Open | High | Low | Value | Volume |
$3.08 | $3.20 | $3.03 | $6.129M | 1.943M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 5788 | $3.15 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$3.18 | 597 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 5839 | 2.140 |
2 | 8947 | 2.130 |
10 | 45269 | 2.120 |
4 | 23275 | 2.110 |
10 | 120548 | 2.100 |
Price($) | Vol. | No. |
---|---|---|
2.160 | 31553 | 7 |
2.170 | 3763 | 1 |
2.180 | 8856 | 1 |
2.200 | 5400 | 1 |
2.220 | 10035 | 1 |
Last trade - 16.10pm 22/11/2024 (20 minute delay) ? |
Featured News
ASB (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online